Overview

Clinical study evaluating selective or nonselective beta blockers use and fracture risk in patients with primary osteoporosis

Eligibility

Inclusion Criteria:

• • Male & female osteoporotic patient aged ≥ 50 years
  • Hypertensive & normotensive patients
  • BMD T-score ≥ 2.5 or more SD below peak bone mass

Exclusion Criteria:

• Patients on drugs that may improve osteoporosis disease state such as:
  • Angiotensin converting enzyme inhibitor (ACEI) or Angiotensin receptor blockers (ARBs), Thiazide diuretic, Nitrates, Spironolactone, Statins.

Patients on drugs that may worsen osteoporosis disease state such as:

        • Corticosteroids, Loop diuretics, Anticonvulsants, Antidepressants, Aromatase inhibitors,
        Thyroid replacement therapy and Proton pump inhibitors.